Načítá se...
Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial
BACKGROUND: Young male cancer survivors have lower testosterone levels, higher fat mass, and worse quality of life (QoL) than age-matched healthy controls. Low testosterone in cancer survivors can be due to orchidectomy or effects of chemotherapy and radiotherapy. We have undertaken a double-blind,...
Uloženo v:
| Vydáno v: | PLoS Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Public Library of Science
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6850530/ https://ncbi.nlm.nih.gov/pubmed/31714912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002960 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|